Psoriatic Arthritis
Conference Coverage
Biologics better solo than with methotrexate in psoriatic arthritis
Ustekinumab or a tumor necrosis factor inhibitor are better used alone than with methotrexate in the treatment of psoriatic arthritis.
From the Journals
Case series suggests biologics, JAK inhibitors safe during pandemic
Investigators saw no increase in hospitalizations versus the general population in New York City.
Feature
Latest data on COVID-19 patients with rheumatic diseases revealed in registry
Data for a total of 583 COVID-19 patients have now been made available.
From the Journals
Financial incentives affect the adoption of biosimilars
Adoption of infliximab biosimilars proceeded more slowly at an academic medical center than at a neighboring VAMC, where financial incentives to...
Feature
‘We’re in great distress here,’ infusion center CMO says
Thrivewell is also deploying a mobile infusion unit to recovered COVID-19 patients who require an infusion for their autoimmune disease.
From the Journals
JAK inhibitors may increase risk of herpes zoster
Patients who received Janus kinase (JAK) inhibitors had a 57% increased relative risk of herpes zoster infection.
From the Journals
Genome study examines heritability of psoriatic disease subtypes
Cutaneous psoriasis shows a greater contribution from genetic variants than does psoriatic arthritis or psoriasis vulgaris.
From the Journals
Rapid shift to adalimumab biosimilars in Denmark contrasts with U.S. experience
The Danish health care system’s shift to adalimumab biosimilars led to substantial decreases in cost.
Multimedia
Psoriasis Therapy During the COVID-19 Pandemic: Should Patients Continue Biologics?
Latest News
AAD-NPF releases first guidelines for nonbiologic treatments of psoriasis
Guidelines for nonbiologic systemic agents for psoriasis provide strong evidence for use of apremilast and guidance for off-label drugs.
Conference Coverage
Secukinumab outperforms adalimumab overall for PsA
MAUI, HAWAII – Results of the 52-week, head-to-head EXCEED study.